HEMATOPOIETIC/LYMPHOID CANCER
Clinical trials for HEMATOPOIETIC/LYMPHOID CANCER explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC/LYMPHOID CANCER trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC/LYMPHOID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ICT01 aims to rally Body's defenses against tough cancers
Disease control OngoingThis study tests a new drug called ICT01, given alone or with the immunotherapy Keytruda, in people with advanced solid tumors or blood cancers that have come back or not responded to treatment. The goal is to see if ICT01 is safe and can help control the cancer by activating a s…
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics • Aim: Disease control
Last updated May 17, 2026 08:48 UTC
-
New CMV strategy aims to protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or disorders. About 153 participants are involved, and the goal is to see if changing when and how anti-CMV drugs are…
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC